TAKEDA PHARMACEUTICAL CO LTD (TAK) — SEC Filings

Latest SEC filings for TAKEDA PHARMACEUTICAL CO LTD (TAK), explained in plain English.

Sentiment Overview: 3 neutral

Recent Filings (3)

• 6-K Filing — 6-K · 2026-03-30T06:27:15-04:00 [neutral]
• Takeda Files Routine 6-K Foreign Issuer Report — 6-K · 2026-03-26T06:03:07-04:00 [neutral]
  Takeda Pharmaceutical Co Ltd filed a 6-K report on March 26, 2026, indicating a routine foreign issuer report. This filing, with accession number 0001395064-26-
• Takeda Files Routine 6-K Report; No New Material Info — 6-K · 2026-03-25T06:03:59-04:00 [neutral]
  Takeda Pharmaceutical Co Ltd filed a routine 6-K report on March 25, 2026, indicating no new material financial or operational information beyond standard repor